ARTEMIS CYSTITIS LIMITED
Significant control: Professor James Malone-Lee (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Artemis Cystitis Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Artemis Cystitis Limited sell?
Registered activity: Specialists medical practice activities (SIC 86220). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
ARTEMIS CYSTITIS LIMITED is an active private limited company (company number 12865469) incorporated on 8 September 2020, registered in London. Its registered activity is specialists medical practice activities (SIC 86220). Latest small accounts cover the period ending 31 March 2025, showing net assets of £151k and cash of £250k, with 3 employees on average. Net assets rose 9% on the prior period (£139k).
By net assets it sits in the top quarter of 2,817 comparable companies in London (median £16k, upper quartile £103k).
Ownership and control
- Professor James Malone-Lee
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 8 September 20206 yrs ago
- Next accounts due
- 31 December 2026in 67 days
- Confirmation statement due
- 22 September 2027in 332 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 86220
- Specialists medical practice activities
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £151k | £250k | £41k | — | — | £26k | 3 |
| 31 March 2024 | £139k | £155k | £67k | — | — | £20k | 3 |
| 31 March 2023 | — | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £150,595 at 31 March 2025
- Cash at bank of £50,000 or moreCash £249,575
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 8 September 2020
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 332 days
- Next accounts duein 67 days
- Accounts period endNet assets £151k · small accounts
- Accounts period endNet assets £139k · small accounts
- Accounts period end
- Incorporated
Similar companies in London
- DOCTOR V LTDBelgravia · inc. Sept 2020
- DOLLIS HEALTH LTDLondon · inc. Sept 2020
- DAN MEDICAL SERVICES LIMITEDLondon · inc. Sept 2020
- MOLECULAR HEPATOLOGY LTDEltham · inc. Sept 2020
- RENEW AND REBALANCE LTDLondon · inc. Sept 2020
- DR.RA LTDLondon · inc. Sept 2020
All companies incorporated on 8 September 2020 · in Sept 2020.
Reminders for ARTEMIS CYSTITIS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.